Blog

LACNETS at the 2024 North American Neuroendocrine Tumor Society (NANETS) Annual Multidisciplinary NET Medical Professional Symposium

19 hours ago2 min read

LACNETS at the 2024 North American Neuroendocrine Tumor Society (NANETS) Annual Multidisciplinary NET Medical Professional Symposium

LACNETS was busy learning from experts and making connections at the 2024 North American Neuroendocrine Tumor Society (NANETS) Annual...

8 views0 comments

LACNETS Team

Nov 132 min read

2024 LACNETS NET CANCER DAY SYMPOSIUM

On November 9th, LACNETS held its 2024 NET Cancer Day Symposium in Santa Monica, California, to recognize and celebrate World NET Cancer...

117 views0 comments

LACNETS Hosts a Regional NET Patient Conference in Minneapolis

LACNETS Team

Sep 263 min read

LACNETS Hosts a Regional NET Patient Conference in Minneapolis

On Saturday, September 21, 2024, over 50 people living with or supporting those living with neuroendocrine cancer gathered for a Regional...

92 views0 comments

Patient Advocacy Organizations Unite at INCA's Global Summit

LACNETS Team

Sep 264 min read

Patient Advocacy Organizations Unite at INCA's Global Summit

LACNETS participated in INCA’s 12th annual Global NET Patient Advocate Summit in Segovia, Spain with 24 other Patient Advocacy...

30 views0 comments

Positive Results of the CABINET Trial Show Cabozantinib as a New, Effective Treatment in Advanced Neuroendocrine Tumors

LACNETS Team

Sep 176 min read

Positive Results of the CABINET Trial Show Cabozantinib as a New, Effective Treatment in Advanced Neuroendocrine Tumors

Dr. Jennifer Chan from Dana Farber Cancer Institute announces the updated findings On Sept 16, 2024, LACNETS interviewed incoming NANETS...

115 views0 comments

Practical Tips For Patients Preparing For Chemotherapy

Lisa Yen, NP, NBC-HWC

Aug 83 min read

Practical Tips For Patients Preparing For Chemotherapy

Neuroendocrine cancer patients often have a variety of available treatment options. Since this cancer behaves differently from other...

188 views0 comments

LACNETS Team

Aug 62 min read

New Progress in Treatment Options...

Exelixis Announces U.S. Food and Drug Administration (FDA) Accepted the Supplemental New Drug Application for Cabozantinib for Patients...

303 views0 comments

LACNETS Team

Apr 231 min read

Breaking News: Lutathera® PRRT Now Approved for Adolescents (12-17 year olds)

On April 23, 2024, the Food and Drug Administration approved lutetium Lu 177 dotatate (Lutathera®, Advanced Accelerator Applications USA,...

109 views0 comments

Tips on Getting Your Scans to Your NET Expert

Shane Peters

Jan 317 min read

Tips on Getting Your Scans to Your NET Expert

by Shane Peters, NET Caregiver, NETCONNECT Mentor Shane also wrote the blog post, “Scan Results: To Check or Not to Check.” “Make sure to...

239 views0 comments

Breaking News: NETTER-2 Trial Supports Lutathera® as 1st Line Treatment

LACNETS Team

Jan 261 min read

Breaking News: NETTER-2 Trial Supports Lutathera® as 1st Line Treatment

The NETTER-2 phase 3 trial results show Lutathera® may be offered as first-line treatment for newly diagnosed grade 2 and 3 advanced...

346 views0 comments

2 3 4 5

Blog

LACNETS PO BOX 370466 DENVER, CO 80237 info@lacnets.org

LACNETS
PO BOX 370466
DENVER, CO 80237

info@lacnets.org